Tag: EpiVax Inc.
EpiVax launches EpiVax Oncology for personalized cancer vaccines
PROVIDENCE — Immunolgy engineering biotech firm EpiVax Inc. has launched EpiVax Oncology Inc., a venture-backed spinoff focused on the development of personalized therapeutic cancer...
EpiVax leads NIH’s $5.8M bird-flu vaccine project
PROVIDENCE - Immunolgy engineering biotech firm EpiVax Inc. is leading a National Institutes of Health-funded $5.8 million collaboration developing a protective vaccine against avian influenza...
Gov. Raimondo, Commerce RI award $193,668 in Innovation Vouchers
Updated at 1:01 p.m.
PROVIDENCE - Four more companies were awarded $193,668 in innovation grants by the R.I. Commerce Corp., Gov. Gina M. Raimondo announced...
EpiVax updates logo to celebrate 19th anniversary
PROVIDENCE – Biotechnology company EpiVax Inc. celebrated its 19th year in business this month with an updated logo and a tease of “other surprises”...
Five Questions With: Nick Inglis
Nick Inglis is the president of the Information Coalition and co-founder of the Information Governance Conference, held annually in Providence. Inglis answers PBN’s questions...
EpiVax licenses tregitope technology to global pharmaceutical firm
PROVIDENCE – EpiVax Inc. said Tuesday it has licensed its immune-modulating technology to a global pharmaceutical company to treat autoimmune disease and allergies.
The biotechnology...
Tech leaders endorse Raimondo’s R.I. Promise scholarship
PROVIDENCE – Leaders of Rhode Island’s technology and IT industries on April 12 announced the formation of an ad-hoc coalition to support Gov. Gina...